Interesting to go back to the previous discussions in this thread.
One of the main question previously was to wonder if the large free cash flow of FY 23 was a one off.
In FY 24, Shape further increased its free cash flow, as the EBITDA increase (+ 33 % to 25.9 m$) was fully reflected in the increase of cash flow from operation (+ 27 % to 30 m$).
Cash flow from operation still largely benefits from the negative working capital model, as the change of working capital had a positive impact of 7.4 m$ on the cash flow, both in FY 23 and FY 24.
So, we can still estimate the free cash flow 24 at 16.8 m$, if we exclude the impact of working capital, after taking into account Capex, lease and share based payment.
It corresponds to a free cash flow yield of 12.4 %, which remains quite high.
- Forums
- ASX - By Stock
- Probably worth more attention
Interesting to go back to the previous discussions in this...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.72 |
Change
0.000(0.00%) |
Mkt cap ! $227.0M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9197 | $2.72 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.72 | 33 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9197 | 2.720 |
3 | 2629 | 2.700 |
1 | 3000 | 2.690 |
1 | 4400 | 2.680 |
1 | 3313 | 2.660 |
Price($) | Vol. | No. |
---|---|---|
2.710 | 1 | 1 |
2.720 | 36 | 2 |
2.730 | 2 | 1 |
2.740 | 1 | 1 |
2.780 | 1828 | 1 |
Last trade - 07.01am 12/11/2024 (20 minute delay) ? |
Featured News
SHA (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online